Please login to the form below

Not currently logged in
Email:
Password:

Santhera

This page shows the latest Santhera news and features for those working in and with pharma, biotech and healthcare.

Encouraging data for GenSight’s blinding retinal disease gene therapy

Encouraging data for GenSight’s blinding retinal disease gene therapy

If approved, the gene therapy would compete with Santhera's Raxone, which became the first approved treatment for LHON in Europe in 2015.

Latest news

More from news
Approximately 5 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Shires's Jeffrey Jonas to lead Sage Shires's Jeffrey Jonas to lead Sage

    The other key appointments are AstraZeneca's Stephen Kanes as chief medical officer and Santhera's Kimi Iguchi as chief financial officer. ... Iguchi joins from her role as chief operating officer, North America, for Santhera.

  • Santhera CEO Klaus Schollmeier joins SuppreMol Santhera CEO Klaus Schollmeier joins SuppreMol

    He has experience at ING BHF-Bank, BASF, Knoll and Abbott. Former CEO of Santhera Pharmaceuticals Klaus Schollmeier has joined Germany-based biopharma SuppreMol as CEO. ... Dr Schollmeier (pictured right) had served as CEO of Santhera since its formation

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Healthcircle Healthcircle

    Novo Nordisk. Otsuka. Pfizer. Roche. Santen. Santhera. Schwabe. Pelviva. Unicough.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics